Why the study?
Does anticoagulant therapy improve outcomes in relatively young males with myocardial infarction?
Does anticoagulant therapy improve outcomes in relatively young males with myocardial infarction?
The excerpt discusses the historical context of anticoagulant therapy in acute myocardial infarction, noting its general favorability but highlighting exceptions in good-risk patients.
Answers are grounded in this paper and cite their sources.
Anticoagulants generally favorable in AMI; challenges routine use and leaves open benefit in good-risk young males.
Article1 November 1961Anticoagulant Therapy in the Relatively Young Male with Myocardial InfarctionJOHN E. MYERS JR., FRANK L. BAUERJOHN E. MYERS JR.Search for more papers by this author, FRANK L. BAUERSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-55-5-760 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAcute myocardial infarction represents a major cause of death in all medically advanced countries of the world. Its immediate mortality rate in this country ranges from 16 to 64%, with an average approaching 30% (1-4). During the past two decades anticoagulants have been added to the rather meager therapeutic program of rest, sedation, oxygen, and analgesics. The vast majority of reports concerning such therapy have been quite favorable, demonstrating a reduction in both mortality and morbidity (5-9). A notable exception has been the work of Russek and Zohman (10), whose good-risk patients treated without anticoagulants have a mortality rate of...References1. RICHARDSBLANDWHITE DWEFPD: A completed twenty-five year follow-up study of 200 patients with myocardial infarction. J. Chron. Dis. 4: 415, 1956. CrossrefMedlineGoogle Scholar2. JUERGENSEDWARDSACHORBURCHELL JLJERWHB: Prognosis of patients surviving first clinically diagnosed myocardial infarction. Arch. Intern. Med. 105: 444, 1960. CrossrefMedlineGoogle Scholar3. WHITEMOOREMARMORSTON AEFJJ: Prognostic features of acute myocardial infarction in men. Arch. Intern. Med. 105: 859, 1960. CrossrefMedlineGoogle Scholar4. BEARDHIPPROBINSTAYLOREBERTBERAN OWHRMJFRVLG: Initial myocardial infarction among 503 veterans. Amer. J. Med. 59: 871, 1960. CrossrefGoogle Scholar5. WRIGHTMARPLEBECK ISCDDF: Report of the committee for the evaluation of anticoagulants in the treatment of coronary thrombosis with myocardial infarction. Amer. Heart J. 36: 801, 1948. CrossrefMedlineGoogle Scholar6. WRIGHTBECKMARPLE ISDFCD: Myocardial infarction and its treatment with anticoagulants: summary of findings for 1031 cases. Mod. Conc. Cardiovas. Dis. 23: 208, 1954. MedlineGoogle Scholar7. MARPLEWRIGHT CDIS: Thromboembolic Conditions and Their Treatment with Anticoagulants, Charles C Thomas, Springfield, 1950. Google Scholar8. WRIGHT IS: Early use of anticoagulants in treatment of myocardial infarction. J. A. M. A. 163: 918, 1957. CrossrefMedlineGoogle Scholar9. CONRADROTHERMICH FGNO: Clinicopathological study of acute myocardial infarction and the role of anticoagulation therapy. Arch. Intern. Med. 103: 421, 1959. CrossrefGoogle Scholar10. RUSSEKZOHMAN HIBL: Limited use of anticoagulants in acute myocardial infarction. J. A. M. A. 163: 922, 1957. CrossrefMedlineGoogle Scholar11. GURNERUNGERLEIDER RSHF: Long-term prognosis and insurability in coronary heart disease. Amer. J. Med. 58: 436, 1959. Google Scholar12. GUBNER RS: Personal communication. Google Scholar13. FRENCHDOCK AJW: Fatal coronary arteriosclerosis in young soldiers. J. A. M. A. 124: 1233, 1944. CrossrefGoogle Scholar14. YATERTRAUMBROWNFITZGERALDGEISLERWILCOX WMAHWGRPMABB: Coronary artery disease in men 18 to 39 years of age. Amer. Heart J. 36: 334, 481, 683, 1948. CrossrefMedlineGoogle Scholar15. YATERWELSHSTAPLETONCLARK WMPPJFML: Comparison of clinical and pathologic aspects of coronary artery disease in men of various age groups: a study of 950 autopsied cases from the Armed Forces Institute of Pathology. Ann. Intern. Med. 34: 352, 1951. LinkGoogle Scholar16. ENOSHOLMESBEYER WFRHJ: Coronary disease among United States soldiers killed in action in Korea. J. A. M. A. 152: 1090, 1953. CrossrefMedlineGoogle Scholar17. NEWMAN M: Coronary occlusion in young adults. Lancet 2: 409, 1946. CrossrefMedlineGoogle Scholar18. MORITZZAMCHECK ARN: Sudden and unexpected deaths of young soldiers. Arch. Path. 42: 459, 1946. MedlineGoogle Scholar19. COUNTRY JC: Myocardial infarction in young men. U. S. Armed Forces Med. J. 5: 688, 1954. MedlineGoogle Scholar20. FRIEDBERG CK: Diseases of the Heart. W. B. Saunders Co., Philadelphia and London, 1956. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: JOHN E. MYERSJR.; FRANK L. BAUERAffiliations: From the Medical Service, DeWitt Army Hospital, Fort Belvoir, Va.Requests for reprints should be addressed to Captain John E. Myers, Jr., MC, Assistant Chief, Medical Service, DeWitt Army Hospital, Fort Belvoir, Va. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAn overview of anticoagulant therapy for coronary artery diseaseThe Use of Anticoagulants in Coronary Heart Disease 1 November 1961Volume 55, Issue 5Page: 760-764KeywordsAnticoagulant therapyAnticoagulantsDeath ratesMedical servicesMorbidityMortalityMyocardial infarctionOxygenSedationThrombosis ePublished: 1 December 2008 Issue Published: 1 November 1961 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Myers et al. (1961) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: